New Lilly, BI diabetes med hits shelves; AstraZeneca launches online tool for docs;

> Eli Lilly ($LLY) and Boehringer Ingelheim's new Type 2 diabetes treatment Jardiance is now available in U.S. pharmacies. Release

> AstraZeneca ($AZN) has launched a new online tool in the U.S. to help medical professionals keep better up to date with their areas of study. More

> Valeant Canada has acquired Valeo Pharma's dermatology product portfolio and several specialty products. Release | Report

> Copenhagen has become the second city involved in Novo Nordisk's ($NVO) global "Cities Changing Diabetes" campaign. Story

> Mylan ($MYL) chose three kids with potentially life-threatening allergies to join NFL star Adrian Peterson to film an educational video about anaphylaxis. Release

And Finally... Merck ($MRK) has started the second year of a 5-year project to fight diabetes by supporting E-Learning in Africa. More

Suggested Articles

Breztri Aerosphere, AZ's three-in-one COPD inhaler, just won its first global nod to rival GlaxoSmithKline's Trelegy Ellipta.

Could an overhauled marketing campaign featuring new pain data help sales of Ironwood and Allergan’s struggling GI drug Linzess?

Forget the charts and graphs. Lead with your heart. That’s the message from Attila Cansun, a chief marketing officer at the newly rebranded P&G Health.